FOR IMMEDIATE RELEASE
Media and Organization Contact:
WHAM HOSTS 3NOT30 FORUM: ACCELERATING RESEARCH AND INVESTMENT IN THE HEALTH OF WOMEN OVER THE NEXT THREE YEARS
Greenwich, CT (November 8, 2023) — On November 2nd, Women’s Health Access Matters (WHAM), in collaboration with Northwell Health’s Katz Institute for Women’s Health and KPMG Foundation, came together with thought leaders from research institutions and the investment community, aligned to create innovative strategies to drive improved health outcomes and economic gains to society.
Michael Dowling, CEO of Northwell Health, opened the Forum characterizing the meeting as a “partnership between two extraordinary organizations. One led by extraordinary leader Carolee Lee and Northwell’s Katz Institute for Women’s Health led by Dr. Stacey Rosen with the extraordinary vision and support of Iris and Saul Katz. Two organizations that have a very common mission. That is the issue of women’s health. Enhancing the focus on women’s health. The uniqueness of women’s health. The importance of looking at every aspect of women’s health. The access to care. The research that needs to be done on women’s health.”
The event included a lineup of esteemed panelists and speakers, with four engaging sessions designed to address critical aspects of women’s health research and investment:
- “Beyond Boundaries: How Diversity & Equity Shape Clinical Trials” explored methods to eliminate barriers for diverse participation in clinical trials, ensuring medical advancements benefit all.
- “Beyond Good Science: Women’s Health Research as an Economic Game Changer” discussed the economic impact of women’s health research and bridging the gender gap in healthcare research.
- “Breaking the Cycle: Capitalizing on The Explosive Growth Opportunities Investing in The Health of Women”explored the imperative of investing in women’s health and unlocking untapped growth opportunities in diagnostics, treatments, and prevention.
- “Accessing Alternate Sources of Capital to Drive Innovation at Scale” confronted gender bias in funding allocation and finding solutions for women-led ventures.
Carolee Lee, CEO and Founder of WHAM, stated that, “We don’t have another 30 years to wait. And we can’t improve health care or access to health care without including women in research. In order to keep up with the innovation, which is rapidly happening, investing in research and business in women’s health is a mandate which can shift healthcare outcomes, reduce economic burden, promote gender equality, and create economic opportunities. It is a strategic investment and commitment that creates more productive and healthier societies.”
The 3Not30 Forum Series is an important follow up to the commitment made on June 13th in Washington, DC, when leaders from diverse fields commemorated the 30th Anniversary of The NIH Revitalization Act of 1993, which established guidelines for women to participate in research and clinical trials. Although some progress has been made since that landmark legislation, WHAM Report data commissioned with RAND Corporation across diseases that differently and differentially impact women shows there is still work to be done. Their pledge to drive substantial change within the next three years, rather than waiting another 30, serves as the foundation for this imperative of change, embodied in 3Not30.
To stay informed about the WHAM 3Not30 Campaign, please sign up for WHAM’s newsletter here. And follow WHAM throughout the year on Instagram, LinkedIn, and Twitter to stay updated on other #3Not30 activities and the latest in women’s health research.
About WHAM (Women’s Health Access Matters)
Women’s health is an economic issue we can’t afford to ignore. WHAM works to increase awareness of and funding for women’s health research and investment by accelerating scientific discovery in women’s health in four primary disease verticals – autoimmune disease, brain health, cancer, and heart health. The WHAM Report quantifies the economic opportunity for investing in women’s health, looking across diseases that impact women differently and differentially, including coronary artery disease, rheumatoid arthritis, and Alzheimer’s disease.Learn more at www.thewhamreport.org and www.whamnow.org.